Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial

UW Pediatrics first author
Sandra Juul
Et. al
and additional authors
Publication Date
Link to article
https://pubmed.ncbi.nlm.nih.gov/38030319/
DOI
10.1016/S2352-3026(23)00285-5
PMID
38030319
Journal name
Lancet Haematol.